LCMS webinars focusing on GPC/SEC - page 1

Tosoh Tuesday - Exploring the AAV Toolkit

Tosoh Tuesday - Exploring the AAV Toolkit

Improve AAV analysis and purification. Learn how to increase recovery and purity using the TOYOPEARL GigaCap Q-650S resin and columns from Tosoh Bioscience.
RECORD
|
Already taken place Tu, 23.6.2026
Tosoh Bioscience
tag
share
more
Tosoh Tuesday - Exploring the AAV Toolkit
Advancing Size Exclusion Chromatography (SEC) for Characterization of Genetic Therapeutics

Advancing Size Exclusion Chromatography (SEC) for Characterization of Genetic Therapeutics

Optimize size exclusion chromatography for genetic therapeutics. Learn how wide-pore SEC columns enable high-resolution profiling of mRNA, LNPs, and viral vectors while preventing shear degradation.
RECORD
|
Already taken place Th, 18.6.2026
Waters Corporation
tag
share
more
Advancing Size Exclusion Chromatography (SEC) for Characterization of Genetic Therapeutics
Which Detector Do You Need for GLP-1RAs? Choosing Between MALS and Mass Spec

Which Detector Do You Need for GLP-1RAs? Choosing Between MALS and Mass Spec

This webinar explains how multi-angle light scattering (MALS) and mass spectrometry (MS) provide complementary insights into GLP-1RA quality.
RECORD
|
Already taken place Tu, 16.6.2026
Waters Corporation
tag
share
more
Which Detector Do You Need for GLP-1RAs? Choosing Between MALS and Mass Spec
Is your Biosimilar, Similar?

Is your Biosimilar, Similar?

Explore regulatory expectations and advanced SEC-MALS workflows for biosimilarity assessment of monoclonal antibodies, including CQAs, aggregation analysis, and impurity profiling.
RECORD
|
Already taken place Th, 28.5.2026
Waters Corporation
tag
share
more
Is your Biosimilar, Similar?
Reliable GLP-1 Aggregate Analysis Using Biozen dSEC

Reliable GLP-1 Aggregate Analysis Using Biozen dSEC

This webinar provides an exploration of peptide aggregation mechanisms and how SEC can be applied to characterize these critical quality attributes.
RECORD
|
Already taken place We, 27.5.2026
Phenomenex
tag
share
more
Reliable GLP-1 Aggregate Analysis Using Biozen dSEC
Beyond Surface Separation: Navigating Mega Molecule Sizing with Wide Pore SEC-MALS

Beyond Surface Separation: Navigating Mega Molecule Sizing with Wide Pore SEC-MALS

Understand how pore structure impacts SEC separations of large biomolecules. Learn how SEC-MALS enables accurate sizing, aggregation analysis, and robust method development.
RECORD
|
Already taken place We, 20.5.2026
Waters Corporation
tag
share
more
Beyond Surface Separation: Navigating Mega Molecule Sizing with Wide Pore SEC-MALS
Size variant analysis of antibodies and ADCs using SEC, SEC-MALS, SEC-MS, and 2D Protein A-SEC Methods

Size variant analysis of antibodies and ADCs using SEC, SEC-MALS, SEC-MS, and 2D Protein A-SEC Methods

Size‑exclusion chromatography (SEC) is essential for analyzing aggregates, monomers, and fragments in biotherapeutic proteins.
RECORD
|
Already taken place Tu, 12.5.2026
Waters Corporation
tag
share
more
Size variant analysis of antibodies and ADCs using SEC, SEC-MALS, SEC-MS, and 2D Protein A-SEC Methods
Fundamentals First Bio Series – SEC for Biologics

Fundamentals First Bio Series – SEC for Biologics

Master SEC fundamentals for biopharma—covering principles, column selection, and troubleshooting with real-world applications in mAbs, AAVs, and nucleic acids.
RECORD
|
Already taken place We, 29.4.2026
Phenomenex
tag
share
more
Fundamentals First Bio Series – SEC for Biologics
Tosoh Tuesday - What is MALS & When is it Useful?

Tosoh Tuesday - What is MALS & When is it Useful?

Join Tosoh Tuesday to explore MALS fundamentals, practical implementation, and real-world SEC-MALS applications for polymer and biologics characterization.
RECORD
|
Already taken place Tu, 28.4.2026
Tosoh Bioscience
tag
share
more
Tosoh Tuesday - What is MALS & When is it Useful?
Navigating Regulatory Guidance for LNP and Liposomal Drug Characterization Using FFF-MALS

Navigating Regulatory Guidance for LNP and Liposomal Drug Characterization Using FFF-MALS

Learn how FFF-MALS enables comprehensive characterization of lipid nanoparticles and liposomes, supporting regulatory-relevant CQAs such as size, morphology, and encapsulation efficiency.
RECORD
|
Already taken place We, 25.3.2026
Waters Corporation
tag
share
more
Navigating Regulatory Guidance for LNP and Liposomal Drug Characterization Using FFF-MALS
 

Related content

PFAS in Water: Why We’re Missing 96% of the Problem

PFAS in Water: Why We’re Missing 96% of the Problem

Fr, 26.6.2026
Organomation
New technology streamlines the development of aptamers, synthetic alternatives to antibodies

New technology streamlines the development of aptamers, synthetic alternatives to antibodies

Fr, 26.6.2026
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
Clarity Chromatography Software 10.2 released!

Clarity Chromatography Software 10.2 released!

Th, 25.6.2026
DataApex
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike